Search alternatives:
point decrease » point increase (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
point decrease » point increase (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
-
19941
Patients’ characteristics, patient number, and US images amounts of BA and non-BA groups.
Published 2022Subjects: -
19942
-
19943
The identification results of test patients with disagreement of individual US image by ShuffleNet.
Published 2022Subjects: -
19944
-
19945
-
19946
-
19947
Ferroelectricity and a 1/3-Magnetization Plateau in the Polar Magnet LiFeV<sub>2</sub>O<sub>7</sub> with Fe<sup>3+</sup> Ions in a Twisted Diamond Chain
Published 2025“…LiFeV<sub>2</sub>O<sub>7</sub> crystallizes in a polar monoclinic <i>Cc</i> structure, where Fe<sup>3+</sup> (<i>S</i> = 5/2) ions form diamond chains along the [101] direction, each surrounded by four neighboring chains. …”
-
19948
-
19949
-
19950
-
19951
-
19952
-
19953
-
19954
-
19955
-
19956
PM26, a specific antagonist of DC-SIGN, can inhibit DC-SIGN/S protein interaction and trans-infection of VSV/SARS-CoV-2.
Published 2021“…<b>(D)</b> Inhibition of trans-infection of Jurkat DC-SIGN with SARS-CoV-2-pseudotyped rVSV-luc. Bars correspond to mean ± SEM of triplicates from an experiment of inhibition of SARS-CoV-2 trans-infection. …”
-
19957
Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction
Published 2024“…No significant difference of ECD was found in the high (2823.45 ± 274.75 cells/mm<sup>2</sup>) and super-high myopia (2856.71 ± 323.53cells/mm<sup>2</sup>) at the visit of 5 years. Compared to baseline, we observed a significant increase in IOP at the 1-week follow-up, which decreased significantly at the one-month visit. …”
-
19958
-
19959
-
19960
DDC for four anticoagulants from 2019 to 2023.
Published 2025“…The DDC value of rivaroxaban experienced a substantial decrease over the past five years (<i>p</i> = 0.020), declining from 55.20 Chinese Yuan (CNY) in 2019 to 4.28 CNY in 2023. …”